NO20030295D0 - Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser - Google Patents
Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelserInfo
- Publication number
- NO20030295D0 NO20030295D0 NO20030295A NO20030295A NO20030295D0 NO 20030295 D0 NO20030295 D0 NO 20030295D0 NO 20030295 A NO20030295 A NO 20030295A NO 20030295 A NO20030295 A NO 20030295A NO 20030295 D0 NO20030295 D0 NO 20030295D0
- Authority
- NO
- Norway
- Prior art keywords
- valproic acid
- manners
- derivatives
- treatment
- bipolar disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22010200P | 2000-07-21 | 2000-07-21 | |
PCT/US2001/023116 WO2002007677A2 (en) | 2000-07-21 | 2001-07-20 | Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20030295D0 true NO20030295D0 (no) | 2003-01-20 |
NO20030295L NO20030295L (no) | 2003-01-20 |
Family
ID=22822065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20030295A NO20030295L (no) | 2000-07-21 | 2003-01-20 | Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser |
Country Status (16)
Country | Link |
---|---|
US (2) | US6555585B2 (zh) |
EP (1) | EP1303289A4 (zh) |
JP (1) | JP2004520263A (zh) |
KR (1) | KR100843703B1 (zh) |
CN (1) | CN1251758C (zh) |
AU (1) | AU2001280699A1 (zh) |
CA (1) | CA2416821A1 (zh) |
CZ (1) | CZ2004266A3 (zh) |
HU (1) | HUP0600526A2 (zh) |
IL (1) | IL153942A0 (zh) |
MX (1) | MXPA03000547A (zh) |
NO (1) | NO20030295L (zh) |
NZ (1) | NZ523917A (zh) |
PL (1) | PL365588A1 (zh) |
WO (1) | WO2002007677A2 (zh) |
ZA (1) | ZA200300641B (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100843703B1 (ko) * | 2000-07-21 | 2008-07-04 | 이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 | 양극성 장애에서의 조증을 치료하기 위한 벨프로익산 및 2-벨프로에닉산 아미드 유도체의 용도 |
CA2508855A1 (en) * | 2002-12-16 | 2004-07-01 | Frank Slade Abbott | Valproic acid analogues and pharmaceutical compositions thereof |
WO2004071424A2 (en) * | 2003-02-05 | 2004-08-26 | Teva Pharmaceutical Industries, Ltd. | Immediate release formulation of n-(2-propylpentanoyl)glycinamide |
US20040175423A1 (en) * | 2003-02-05 | 2004-09-09 | Daniella Licht | Sustained release formulation of N- (2-propylpentanoyl) glycinamide and related compounds |
IL157751A0 (en) * | 2003-02-28 | 2004-03-28 | Yissum Res Dev Co | New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them |
IL156203A0 (en) * | 2003-05-29 | 2003-12-23 | Yissum Res Dev Co | Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders |
EP1491188A1 (en) * | 2003-06-25 | 2004-12-29 | G2M Cancer Drugs AG | Topical use of valproic acid for the prevention or treatment of skin disorders |
US20060004098A1 (en) * | 2003-07-28 | 2006-01-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compounds useful for treating neurological disorders |
EP1713486A4 (en) * | 2003-12-02 | 2009-04-29 | Sheldon Leslie James | COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY |
WO2006012603A2 (en) * | 2004-07-22 | 2006-02-02 | Nps Pharmaceuticals, Inc. | Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases |
US20080234213A1 (en) * | 2005-09-02 | 2008-09-25 | Matthias Wabl | Oncogenic regulatory RNAs for diagnostics and therapeutics |
US7459280B2 (en) * | 2006-02-27 | 2008-12-02 | Picobella, Llc | Methods for diagnosing and treating kidney cancer |
US20080267977A1 (en) * | 2007-04-26 | 2008-10-30 | Friedrich-Alexander University Of Erlangen-Nuremberg | Combined immunological agent and sensitizing agent for the treatment of cancer |
CN106715695B (zh) | 2014-02-05 | 2020-07-31 | 耶达研究及发展有限公司 | 用于治疗和诊断的微rna和包含所述微rna的组合物 |
IL267195B2 (en) * | 2016-12-14 | 2024-05-01 | Sk Biopharmaceuticals Co Ltd | Use of carbamate compounds to prevent, alleviate, or treat bipolar disorder |
IL282188A (en) | 2021-04-08 | 2022-11-01 | Yeda Res & Dev | Combined use of ketamine and bretigabine for the treatment of psychiatric disorders |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU988188A3 (ru) | 1973-12-14 | 1983-01-07 | Эсакмадьяросаги Ведьимювек (Инопредприятие) | Способ получени N,N-дизамещенных амидов карбоновых кислот |
DE3050800C2 (zh) | 1979-03-22 | 1989-06-22 | Continental Pharma Inc., Bruessel/Bruxelles, Be | |
US4301176A (en) * | 1980-08-18 | 1981-11-17 | Warner-Lambert Company | Method of administering calcium valproate |
FR2489319A1 (fr) | 1980-08-27 | 1982-03-05 | Clin Midy | Derives de l'acide amino-4 butyrique et les medicaments, actifs notamment sur le systeme nerveux central, en contenant |
BE885303A (fr) | 1980-09-19 | 1981-03-19 | Continental Pharma | Glycinamides |
LU83729A1 (fr) * | 1981-11-04 | 1983-09-01 | Galephar | Sels d'acide valproique,leur preparation et leur utilisation |
DK373383A (da) | 1982-08-20 | 1984-02-21 | Midit | Fremgangsmaade til fremstilling af omega-aminosyrederivater |
US4913906B1 (en) | 1985-02-28 | 2000-06-06 | Yissum Res Dev Co | Controlled release dosage form of valproic acid |
IT1190133B (it) | 1986-06-19 | 1988-02-10 | Chiesi Farma Spa | Derivati di acido valproico e di acido (e)-2-valproenoico,procedimento per la loro preparazione e relative composizioni farmaceutiche |
DE3785667T2 (de) | 1986-09-17 | 1994-07-21 | Clintec Nutrition Co | Zusatznahrung bzw. therapie für personen mit risiko oder in behandlung für arteriosklerotische vaskuläre, kardiovaskuläre und/oder thrombotische erkrankungen. |
US5169642A (en) * | 1988-06-24 | 1992-12-08 | Abbott Laboratories | Sustained-release drug dosage units |
US6287598B1 (en) * | 1993-05-28 | 2001-09-11 | Alza Corporation | Method for providing sustained antiepileptic therapy |
US5585358A (en) * | 1993-07-06 | 1996-12-17 | Yissum Research Development Corporation Of The Hebrew University Of Jerusalem | Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents |
PL187926B1 (pl) | 1996-03-25 | 2004-11-30 | Lilly Co Eli | Kompozycja farmaceutyczna do leczenia bólu |
IL121268A0 (en) | 1997-07-09 | 1998-01-04 | Dpharm Ltd | Branched chain fatty acids their derivatives and use in the treatment of central nervous system disorders |
JP2002518442A (ja) | 1998-06-22 | 2002-06-25 | アメリカン・バイオジェネティック・サイエンシズ・インコーポレーテッド | 偏頭痛及び情動病の治療及び予防用バルプロ酸類似物の用法 |
KR100843703B1 (ko) * | 2000-07-21 | 2008-07-04 | 이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 | 양극성 장애에서의 조증을 치료하기 위한 벨프로익산 및 2-벨프로에닉산 아미드 유도체의 용도 |
-
2001
- 2001-07-20 KR KR1020037000586A patent/KR100843703B1/ko not_active IP Right Cessation
- 2001-07-20 HU HU0600526A patent/HUP0600526A2/hu unknown
- 2001-07-20 JP JP2002513415A patent/JP2004520263A/ja active Pending
- 2001-07-20 IL IL15394201A patent/IL153942A0/xx not_active IP Right Cessation
- 2001-07-20 WO PCT/US2001/023116 patent/WO2002007677A2/en active IP Right Grant
- 2001-07-20 EP EP01959110A patent/EP1303289A4/en not_active Withdrawn
- 2001-07-20 CN CNB018139663A patent/CN1251758C/zh not_active Expired - Fee Related
- 2001-07-20 CA CA002416821A patent/CA2416821A1/en not_active Abandoned
- 2001-07-20 CZ CZ2004266A patent/CZ2004266A3/cs unknown
- 2001-07-20 US US09/910,543 patent/US6555585B2/en not_active Expired - Fee Related
- 2001-07-20 NZ NZ523917A patent/NZ523917A/en unknown
- 2001-07-20 AU AU2001280699A patent/AU2001280699A1/en not_active Abandoned
- 2001-07-20 PL PL01365588A patent/PL365588A1/xx not_active Application Discontinuation
- 2001-07-20 MX MXPA03000547A patent/MXPA03000547A/es active IP Right Grant
-
2003
- 2003-01-20 NO NO20030295A patent/NO20030295L/no not_active Application Discontinuation
- 2003-01-23 ZA ZA200300641A patent/ZA200300641B/en unknown
- 2003-04-28 US US10/425,375 patent/US20030212142A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002007677A2 (en) | 2002-01-31 |
MXPA03000547A (es) | 2004-04-05 |
IL153942A0 (en) | 2003-07-31 |
US20030212142A1 (en) | 2003-11-13 |
CN1446097A (zh) | 2003-10-01 |
EP1303289A2 (en) | 2003-04-23 |
CA2416821A1 (en) | 2002-01-31 |
JP2004520263A (ja) | 2004-07-08 |
KR100843703B1 (ko) | 2008-07-04 |
AU2001280699A1 (en) | 2002-02-05 |
CZ2004266A3 (cs) | 2005-02-16 |
KR20030036610A (ko) | 2003-05-09 |
EP1303289A4 (en) | 2009-08-05 |
PL365588A1 (en) | 2005-01-10 |
CN1251758C (zh) | 2006-04-19 |
NO20030295L (no) | 2003-01-20 |
HUP0600526A2 (en) | 2006-11-28 |
US6555585B2 (en) | 2003-04-29 |
ZA200300641B (en) | 2004-01-26 |
NZ523917A (en) | 2004-11-26 |
US20020103237A1 (en) | 2002-08-01 |
WO2002007677A3 (en) | 2002-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
NO20030295L (no) | Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser | |
NO20001754D0 (no) | Prostaglandinagonister og anvendelse derav for behandling av benforstyrrelser | |
PL361849A1 (en) | Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours | |
NO20022585D0 (no) | Pyrrolidinacetamidderivat alene eller i kombinasjon for behandling av CNS-forstyrrelser | |
HUP0104425A3 (en) | Anthranilic acid amides and the use thereof for the treatment of angiogenesis | |
ATE455106T1 (de) | Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen | |
NO20041588L (no) | Anvendelse av flibanserin ved behandling av seksuelle forstyrrelser | |
EE04854B1 (et) | Oksabispidiinühendid, nende valmistamise meetod ning ravimvorm kasutamiseks südame arütmia raviks ja profülaktikaks | |
NO20031903L (no) | Nye amidoalkylpiperidin- og amidoalkylpiperazinderivater for anvendelse vedbehandling av nervesystemlidelser | |
HK1045986B (zh) | 含羥基二十碳四烯酸衍生物的合成劑及其用於治療乾眼病症的方法 | |
NO20001412D0 (no) | Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser | |
NO20032340D0 (no) | Substituerte derivater av aminofuran-2-yl-eddiksyre og aminotien-2-yl-eddiksyre og deres anvendelse for behandling av migrene og smerte | |
NO20006506D0 (no) | Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer | |
AU2002220735A1 (en) | Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain | |
ITMI20010957A0 (it) | Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche | |
HK1057332A1 (en) | Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders | |
EE200100527A (et) | Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks | |
EP1150669A4 (en) | FORMULATIONS ON L-ARGININE BASE FOR DISEASE TREATMENT AND USE THEREOF | |
NO985974D0 (no) | Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer | |
AU2002210763A1 (en) | Use of 1-ebio in the treatment of bipolar disorders | |
NO20010569D0 (no) | Proteaseinhibitorer for anvendelse ved behandling av psoriasis | |
IL151493A0 (en) | Use of dermaciclane for the treatment of anxiety and depression | |
AU2001254825A1 (en) | Butenoic acids derivatives and their use in the treatment of rhinitis | |
DE60102471D1 (de) | Indolderivate zur verwendung in der behandlung von zns-störungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |